Johan Sein

Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With Autologous<i>GM-CSF</i>–Transduced Tumor Cells in Metastatic Melanoma Patients

Rosalie M. Luiten, Esther W. M. Kueter, Wolter J. Mooi et al. · Journal of Clinical Oncology · 2005 · 106 citations · Full text

Medicine, Immunology, Oncology +17

Initial experience with treatment of human B cell lymphoma with anti-CD19 monoclonal antibody

Annemarie Hekman, A. Honselaar, Wim M.J. Vuist et al. · Cancer Immunology Immunotherapy · 1991 · 92 citations · Full text

Medicine, Hematology, Oncology +12

Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.

G C de Gast, Heinz‐Josef Klümpen, Florry A. Vyth‐Dreese et al. · PubMed · 2000 · 60 citations

Medicine, Oncology, Pharmacology +17

Eradication of large human B cell tumors in nude mice with unconjugated CD20 monoclonal antibodies and interleukin 2.

Erik Hooijberg, Johan Sein, P C van den Berk et al. · PubMed · 1995 · 50 citations

Life Sciences, Immunology, Oncology +15

On the Role of Melanoma-Specific CD8+ T-Cell Immunity in Disease Progression of Advanced-Stage Melanoma Patients

Monique van Oijen, Adriaan D. Bins, Sjoerd G. Elias et al. · Clinical Cancer Research · 2004 · 50 citations · Full text

Life Sciences, Immunology, Oncology +17